Evidence map›Paper›PMID 36429820›Full record

ArticleInternational journal of environmental research and public health2022

Tuberculosis and Sexual and Reproductive Health of Women in Four African Countries.

Rayan Korri, Abhishek Bakuli, Olumuyiwa A Owolabi, Julieth Lalashowi, Cândido Azize, Mohammed Rassool, Farzana Sathar, Andrea Rachow, Olena Ivanova, TB Sequel Consortium

Open access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 5 countries.

Rayan KorriDivision of Infectious Diseases and Tropical Medicine, Medical Centre of the University of Munich (LMU), 80802 Munich, Germany.ORCID 0000-0001-7014-2635
Abhishek BakuliDivision of Infectious Diseases and Tropical Medicine, Medical Centre of the University of Munich (LMU), 80802 Munich, Germany.ORCID 0000-0001-5123-1974
Olumuyiwa A OwolabiMedical Research Council Unit, The Gambia at the London School of Hygiene and Tropical Medicine, Banjul P.O. Box 273, The Gambia.
Julieth LalashowiNational Institute for Medical Research (NIMR), Mbeya Medical Research Centre, Mbeya P.O. Box 2410, Tanzania.
Cândido AzizeInstituto Nacional de Saúde (INS), Marracuene 3943, Mozambique.
Mohammed RassoolClinical HIV Research Unit, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of Witwatersrand, Johannesburg 2092, South Africa.
Farzana SatharThe Aurum Institute, Johannesburg 2194, South Africa.
Andrea RachowDivision of Infectious Diseases and Tropical Medicine, Medical Centre of the University of Munich (LMU), 80802 Munich, Germany.
Olena IvanovaDivision of Infectious Diseases and Tropical Medicine, Medical Centre of the University of Munich (LMU), 80802 Munich, Germany.ORCID 0000-0002-8276-7891
TB Sequel Consortium
German Center for Infection Research · DELudwig-Maximilians-Universität München · DEAurum Institute · ZAInstituto Nacional de Saúde · MZMRC Unit the Gambia · GMNational Institute for Medical Research · TZUniversity of the Witwatersrand · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tuberculosis (TB) is a major reason of maternal mortality in low-income countries, and it increases the probability of adverse sexual and reproductive health (SRH) outcomes, including ectopic pregnancy and perinatal mortality. The data presented here is from the TB Sequel observational cohort conducted in four African countries. For this sub-study, we selected only female participants, who were diagnosed with drug susceptible TB and followed-up until the end of anti-TB treatment. The data collection included questionnaires, clinical examination and laboratory tests at TB diagnosis, day 14, month 2, 4 and 6. A total of 486 women, with 88.3% being 18-49 years old, were included in the analysis. Around 54.7% were HIV positive. Most of the participants (416/486; 85.6%) in our cohort were considered cured at month 6. Only 40.4% of non-pregnant women of reproductive age used contraception at TB diagnosis. A total of 31 out of 486 women experienced pregnancy during TB treatment. Pregnancy outcomes varied between live birth (16/31; 51.6%), induced abortion (6/31; 19.4%), miscarriage (4/31; 12.9%) and stillbirth (3/31; 9.6%). Integration and linking of SRH services with TB programmes are vital to increase contraception use and protect women from obstetric risks associated with pregnancy during TB treatment.

Indexed as

Pregnancy Complications, InfectiousSexual HealthTuberculosisAdolescentAdultFemaleHumansMiddle AgedPregnancyReproductive HealthSexual BehaviorYoung AdultAfricapregnancysexual and reproductive healthtuberculosis

Identifiers

PMID36429820
PMCPMC9690042
OpenAlexW4309607967

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.